Results 81 to 90 of about 103,720 (239)
A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity
Viruses, 2017 Current measles vaccines suffer from poor effectiveness in young infants due primarily to the inhibitory effect of residual maternal immunity on vaccine responses.
Emily Julik, Jorge Reyes-del Valle
doaj +1 more source
Measles vaccine virus RNA in children more than 100 days after vaccination [PDF]
, 2019 Jamie McMahon +2 more
openalex +1 more source
VirusesMeasles is a highly contagious viral disease and remains a global health challenge despite the availability of effective vaccines. Although many regions have successfully eliminated measles, outbreaks continue to occur owing to vaccine hesitancy ...
Naruhito Otani +7 more
doaj +1 more source
Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study [PDF]
, 2019 Eliane Matos dos Santos +12 more
openalex +1 more source
KAP Study on Immunization of Children in a City of North India – A 30 Cluster Survey [PDF]
, 2008 Background: To determine the knowledge, attitude and practices about immunization among respondents of children aged 12-23 months.\ud Methods: A total of 510 respondents were interviewed in the urban slums of Lucknow district of India, using 30 cluster ...
Awasthi, Shally +5 more
core
EPI Update, May 18, 2010 [PDF]
, 2010 Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public ...
core
Measles Outbreak in Complex Emergency: Estimating Vaccine Effectiveness and Evaluation of the Vaccination Campaign in Borno State, Nigeria, 2019 [PDF]
, 2021 Anne Eudes Jean Baptiste +14 more
openalex +1 more source
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant [PDF]
, 2021 Michaël Desjardins +8 more
openalex +1 more source